Valuing Clinical Evidence — O’S Winter 2018/19 Print Edition

Description

Description

  • Dustin Sulak: Cannabis as an alternative to opioids
  • Fred Gardner: SCC Spares California from FSMB Guidelines
  • Jeffrey Hergenrather: Cannabis Clinicians in the Legalization Era
  • Jeffrey Hergenrather: Grand Rounds at St. Rose
  • FG: FDA Approval of Epidiolex
  • Melanie Dreher on studying ganja-using moms in Jamaica
  • Cristina Sanchez: Phytocannabinoids as antitumor tools
  • FG: Tod Mikuriya, Raphael Mechoulam, and the Value of Clinical Evidence
  • Paul Armentano: Pattern of Protective Effects Emerges in Studies
  • Deborah Caldwell: The Making of a Topical and Plight of the Artisan
  • Mel Frank: The Cannabis female flower
  • Jack McCue: Evidence-Based Medicine vs Medical Cannabis
  • FG on the National Academy of Sciences Report and ‘Cannabis Use Disorder’
  • Dale Gieringer on the future of Medical Cannabis Research
  • Linda Jackson/David Hadorn The Original Cannabis Telemedicine Practice
  • Pat McCartney —The Reporter Who Exposed The Plot Against Proposition 215
  • Pebbles Trippet’s Achievement; Acknowledgment for Jeff Jones
  • Lynn Barnes/FG Farewell to Dennis Peron Plus Correspondence & Commentary

Order the print edition.